The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy
Authors:
- M. BalicMBM. Balic
- N. DandachiNDN. Dandachi
- M. ReselMRM. Resel
- W. SchippingerWSW. Schippinger
- P. RegitnigPRP. Regitnig
- H. SamoniggHSH. Samonigg
- T. BauernhoferTBT. Bauernhofer
- 1 October 2013
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 46 (15) , 1585-1589
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The role and function of cadherins in the mammary glandBreast Cancer Research, 2012
- Neoadjuvant chemotherapy for locally advanced breast cancer: A review of the literature and future directionsEuropean Journal of Surgical Oncology, 2009
- The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor ActivationJournal of Biological Chemistry, 2008
- Soluble cadherins as cancer biomarkersClinical & Experimental Metastasis, 2007
- Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2006
- Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E‐cadherinCancer, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- The ins and outs of E-cadherin traffickingTrends in Cell Biology, 2004
- Serum E-cadherin concentrations and their response during laparoscopic and open cholecystectomySurgical Endoscopy, 2002
- The E-cadherin–catenin complex in tumour metastasisEuropean Journal of Cancer, 2000